0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Galderma S.A. - logo

Galderma develops, manufactures, and supplies dermatological products, and aesthetic and corrective medical solutions. It focuses on developing products for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis (fungal nail infections), pigmentary disorders, and skin cancer. The company also provides products for skin structure, dry skin, atopic dermatitis, scalp psoriasis and other conditions. The company was founded in 1981 and is headquartered in Lausanne, Switzerland with research and development centers around the world.

Topical Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Topical Drug Delivery - Global Strategic Business Report

  • Report
  • June 2025
  • 94 Pages
  • Global
From
EUR$5,850USDGBP
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
EUR$3,000USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Lotions (Including Sunscreens) Market Report 2025 - Product Thumbnail Image

Lotions (Including Sunscreens) Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Atopic Dermatitis Drugs Market 2024-2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market 2024-2028

  • Report
  • May 2024
  • 175 Pages
  • Global
From
EUR$2,500USDGBP
Acne Drugs - Global Strategic Business Report - Product Thumbnail Image

Acne Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 93 Pages
  • Global
From
EUR$5,850USDGBP
Topical Drug Delivery Market Report 2025 - Product Thumbnail Image

Topical Drug Delivery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Dermatology OTC Medications Market Report 2025 - Product Thumbnail Image

Dermatology OTC Medications Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,750USDGBP
Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,500USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more